摘要:
The N-acetyl-D-galactosamine transferase protein of the present invention is characterized by transferring N-acetyl-D-galactosamine to N-acetyl-D-glucosamine with β1,3 linkage, and it preferably has the amino acid sequence shown in SEQ ID NO: 2 or 4. The canceration assay according to the present invention uses a nucleic acid for measurement which hybridizes under stringent conditions to the nucleotide sequence shown in SEQ ID NO: 1 or 3 or a nucleotide sequence complementary to at least one of them.
摘要翻译:本发明的N-乙酰基-D-半乳糖胺转移酶蛋白的特征在于将N-乙酰基-D-半乳糖胺转移至具有1,3-连接的N-乙酰基-D-葡糖胺,并且其优选具有所示的氨基酸序列 根据本发明的癌化测定使用在严格条件下与SEQ ID NO:1或3所示的核苷酸序列杂交的核酸或与至少一个氨基酸互补的核苷酸序列的核酸 的他们。
摘要:
The N-acetyl-D-galactosamine transferase protein of the present invention is characterized by transferring N-acetyl-D-galactosamine to N-acetyl-D-glucosamine with β1,3 linkage, and it preferably has the amino acid sequence shown in SEQ ID NO: 2 or 4. The canceration assay according to the present invention uses a nucleic acid for measurement which hybridizes under stringent conditions to the nucleotide sequence shown in SEQ ID NO: 1 or 3 or a nucleotide sequence complementary to at least one of them.
摘要翻译:本发明的N-乙酰基-D-半乳糖胺转移酶蛋白的特征在于将N-乙酰基-D-半乳糖胺转移至具有1,3-连接的N-乙酰基-D-葡糖胺,并且其优选具有所示的氨基酸序列 根据本发明的癌化测定使用在严格条件下与SEQ ID NO:1或3所示的核苷酸序列杂交的核酸或与至少一个氨基酸互补的核苷酸序列的核酸 的他们。
摘要:
The N-acetyl-D-galactosamine transferase protein of the present invention is characterized by transferring N-acetyl-D-galactosamine to N-acetyl-D-glucosamine with β1,3 linkage, and it preferably has the amino acid sequence shown in SEQ ID NO: 2 or 4. The canceration assay according to the present invention uses a nucleic acid for measurement which hybridizes under stringent conditions to the nucleotide sequence shown in SEQ ID NO: 1 or 3 or a nucleotide sequence complementary to at least one of them.
摘要翻译:本发明的N-乙酰基-D-半乳糖胺转移酶蛋白的特征在于将N-乙酰基-D-半乳糖胺转移至具有β1,3键的N-乙酰基-D-葡糖胺,并且其优选具有SEQ所示的氨基酸序列 根据本发明的癌化测定使用在严格条件下与SEQ ID NO:1或3所示的核苷酸序列杂交的核酸或与至少一种互补的核苷酸序列的核酸 。
摘要:
The N-acetyl-D-galactosamine transferase protein of the present invention is characterized by transferring N-acetyl-D-galactosamine to N-acetyl-D-glucosamine with β1,3 linkage, and it preferably has the amino acid sequence shown in SEQ ID NO: 2 or 4. The canceration assay according to the present invention uses a nucleic acid for measurement which hybridizes under stringent conditions to the nucleotide sequence shown in SEQ ID NO: 1 or 3 or a nucleotide sequence complementary to at least one of them.
摘要翻译:本发明的N-乙酰基-D-半乳糖胺转移酶蛋白的特征在于将N-乙酰基-D-半乳糖胺转移至具有1,3-连接的N-乙酰基-D-葡糖胺,并且其优选具有所示的氨基酸序列 根据本发明的癌化测定使用在严格条件下与SEQ ID NO:1或3所示的核苷酸序列杂交的核酸或与至少一个氨基酸互补的核苷酸序列的核酸 的他们。
摘要:
Described are an enzyme having an activity to transfer N-acetylglucosamine to a non-reducing terminal of Galβ1-4Glc or Galβ1-4GlcNAc group through β1,3-linkage; nucleic acid coding for the enzyme; and method for diagnosis of a cancer and/or tumor, especially a cancer and/or tumor of a digestive organ, using the expression amount of the gene of the enzyme as an index. A gene coding for a novel enzyme having an activity to transfer N-acetylglucosamine to a non-reducing terminal of Galβ1-4Glc or Galβ1-4GlcNAc group through β1,3-linkage was cloned from human stomach cells, and sequenced, and the enzyme was expressed. Since this enzyme is not produced substantially or at all in cancer and/or tumor cells, especially in cancer or tumor cells of a digestive organ, the cancer and/or tumor may be diagnosed using the expression of the gene of the enzyme as an index.
摘要:
The N-acetyl-D-galactosamine transferase protein of the present invention is characterized by transferring N-acetyl-D-galactosamine to N-acetyl-D-glucosamine with β1,3 linkage, and it preferably has the amino acid sequence shown in SEQ ID NO: 2 or 4. The canceration assay according to the present invention uses a nucleic acid for measurement which hybridizes under stringent conditions to the nucleotide sequence shown in SEQ ID NO: 1 or 3 or a nucleotide sequence complementary to at least one of them.
摘要翻译:本发明的N-乙酰基-D-半乳糖胺转移酶蛋白的特征在于将N-乙酰基-D-半乳糖胺转移至具有β1,3键的N-乙酰基-D-葡糖胺,并且其优选具有SEQ所示的氨基酸序列 根据本发明的癌化测定使用在严格条件下与SEQ ID NO:1或3所示的核苷酸序列杂交的核酸或与至少一种互补的核苷酸序列的核酸 。
摘要:
An enzyme having an activity of transferring N-acetylglucosamine to the non-reducing end of a Galβ1-4Glc or Galβ1-4GlcNAc-group via a β-1,3 bond; a nucleic acid encoding the same; and a method of diagnosing cancer and/or tumor, in particular, digestive cancer and/or tumor using the expression dose of a gene of the above enzyme as an indication. A gene of a novel enzyme having an activity of transferring N-acetylglucosamine to the non-reducing end of a Gal β1-4Glc or Gal β1-4GlcNAc-group via a β-1,3 bond is cloned from human stomach cells and its base sequence is determined. Then this enzyme is expressed. Since this enzyme is scarcely or never produced in cancer and/or tumor, in particular, digestive cancer and/or tumor cells, cancer and/or tumor can be diagnosed with the use of the expression of the enzyme gene as an indication.
摘要:
The N-acetyl-D-galactosamine transferase protein of the present invention is characterized by transferring N-acetyl-D-galactosamine to N-acetyl-D-glucosamine with β1,3 linkage, and it preferably has the amino acid sequence shown in SEQ ID NO: 2 or 4. The canceration assay according to the present invention uses a nucleic acid for measurement which hybridizes under stringent conditions to the nucleotide sequence shown in SEQ ID NO: 1 or 3 or a nucleotide sequence complementary to at least one of them.
摘要翻译:本发明的N-乙酰基-D-半乳糖胺转移酶蛋白的特征在于将N-乙酰基-D-半乳糖胺转移至具有β1,3键的N-乙酰基-D-葡糖胺,并且其优选具有SEQ所示的氨基酸序列 根据本发明的癌化测定使用在严格条件下与SEQ ID NO:1或3所示的核苷酸序列杂交的核酸或与至少一种互补的核苷酸序列的核酸 。
摘要:
An enzyme having an activity of transferring N-acetylglucosamine to the non-reducing end of a Gal β1-4Glc or Gal β1-4GlcNAc-group via a β-1,3 bond; a nucleic acid encoding the same; and a method of diagnosing cancer and/or tumor, in particular, digestive cancer and/or tumor using the expression dose of a gene of the above enzyme as an indication. A gene of a novel enzyme having an activity of transferring N-acetylglucosamine to the non-reducing end of a Gal β1-4Glc or Gal β1-4GlcNAc-group via a β-1,3 bond is cloned from human stomach cells and its base sequence is determined. Then this enzyme is expressed. Since this enzyme is scarcely or never produced in cancer and/or tumor, in particular, digestive cancer and/or tumor cells, cancer and/or tumor can be diagnosed with the use of the expression of the enzyme gene as an indication.
摘要:
It is intended to find a highly specific epithelial ovarian cancer marker and to provide an antibody capable of specifically recognizing and detecting the marker or a fragment of the antibody. The present invention provides an anti-β1,6-N-acetylglucosaminyltransferase 5B antibody for diagnosis of epithelial ovarian cancer, i.e., an antibody for detection of a glycosyltransferase β1,6-N-acetylglucosaminyltransferase 5B as an epithelial ovarian cancer marker. The antibody recognizes, as an epitope, a part of a polypeptide of the enzyme consisting of the amino acid sequence represented by SEQ ID NO: 1.